about
Medical Management of Glaucoma in the 21st Century from a Canadian PerspectiveAn objective assessment of the variability in number of drops per bottle of glaucoma medication.Cost Analysis of Commonly used Combination of Drugs in Primary Open Angle GlaucomaVariation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for GlaucomaSuccess of patient training in improving proficiency of eyedrop administration among various ophthalmic patient populations.Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and SwedenSqueeze Me if You Can: Variability in Force Requirements to Extract a Drop From Common Glaucoma BottlesCost considerations of the new fixed combinations for glaucoma medical therapy.Influence of container structures and content solutions on dispensing time of ophthalmic solutions.Stimuli-sensitive hydrogels: a novel ophthalmic drug delivery systemFactors affecting eye drop instillation in glaucoma patients with visual field defectPrinciples of pharmacology in the eye.The effect of needle gauge, needle type, and needle orientation on the volume of a drop.Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper.Micro-instillation of fluorescein with an inoculation loop for ocular surface staining in dry eye syndrome.Precision Ocular Drug Delivery Via Aerosol Ring Vortices.Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.Oxymetazoline and hypertensive crisis in a child: can we prevent it?High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine.Topical administration of regorafenib eye drops: Phase I dose-escalation study in healthy volunteers.Microspheres as resistive elements in a check valve for low pressure and low flow rate conditions.Study of eye drops dispensing and dose variability by using plastic dropper tips.The design of contact lens based ocular drug delivery systems for single-day use: Part (I) Structural factors, surrogate ophthalmic dyes and passive diffusion studies.
P2860
Q28074316-D2A5B63A-C4FD-4BF1-BCCB-F1489E7FBEFAQ33717101-F6D7A22E-FF3D-4361-A54C-EE9172114830Q35792368-81FF8B90-38BE-4B00-A2C4-6B5ADE03A6DFQ36626793-2432E48D-A56F-4DDC-A032-5D16CAB1BB58Q37179937-E5F1A2D2-2EE6-4C27-9681-5FDF5943C0ADQ37318853-61286326-5C77-44D7-8446-B11710C4B5E0Q39462736-E6861836-0826-4021-BF4E-578986981AA6Q39716940-CA319CA9-539A-4547-8728-57835C9FB7ECQ40838554-4E1CA2A5-83A0-478B-89BF-7EA31071D1E5Q41432115-005250C5-AD71-4775-9FEF-C98A8BAFBB11Q42375698-12CCCFE2-6366-492F-BA85-166E90E099ECQ45871474-ED3BFF56-479F-4EEE-A899-3FE90B2CF741Q46896361-8F254B1F-C257-4470-8814-5857FB4DB109Q46968848-4B771A8D-23D1-49A8-A4F7-29233B879930Q47412333-5E23E734-ABFA-4AB3-A877-33FC0964CB89Q47821762-D6F00CA7-FB84-49F3-B31F-ECDF6D40326AQ47852975-36F67EE6-EF50-4701-99AA-28FFEDD0711DQ48008002-5212DB91-8413-4CCF-BB71-E03F39E61D77Q50094851-638242C6-A0ED-4635-AEDC-FDB13CE0706EQ50119662-640F8C3A-C336-48D2-A82D-E96646E88A5BQ51537678-3BCE323A-1D98-4926-B273-573763470377Q51946038-95CFC182-2491-4ACD-8661-5C020E370A81Q53591049-E22C6C86-CD98-4CA9-8461-1601BE48A937
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Determinants of eye drop size.
@ast
Determinants of eye drop size.
@en
type
label
Determinants of eye drop size.
@ast
Determinants of eye drop size.
@en
prefLabel
Determinants of eye drop size.
@ast
Determinants of eye drop size.
@en
P1476
Determinants of eye drop size.
@en
P2093
Annick Ludwig
Luc Van Santvliet
P304
P356
10.1016/J.SURVOPHTHAL.2003.12.009
P577
2004-03-01T00:00:00Z